Conforma in-licenses Sumitomo's amrubicin

Sumitomo (Osaka, Japan) granted Conforma (San Diego, Calif.) exclusive rights to develop and market amrubicin in North America and Europe. Sumitomo markets the third-generation synthetic anthracycline...